Journal Article DKFZ-2025-00936

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Oncogene aberrations drive medulloblastoma progression, not initiation.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2025
Nature Publ. Group London [u.a.]

Nature 642(8069), 1062-1072 () [10.1038/s41586-025-08973-5]
 GO

This record in other databases:  

Please use a persistent id in citations: doi:

Abstract: Despite recent advances in understanding disease biology, treatment of group 3/4 medulloblastoma remains a therapeutic challenge in paediatric neuro-oncology1. Bulk-omics approaches have identified considerable intertumoural heterogeneity in group 3/4 medulloblastoma, including the presence of clear single-gene oncogenic drivers in only a subset of cases, whereas in most cases, large-scale copy number aberrations prevail2,3. However, intratumoural heterogeneity, the role of oncogene aberrations, and broad copy number variation in tumour evolution and treatment resistance remain poorly understood. To dissect this interplay, we used single-cell technologies (single-nucleus RNA sequencing (snRNA-seq), single-nucleus assay for transposase-accessible chromatin with high-throughput sequencing (snATAC-seq) and spatial transcriptomics) on a cohort of group 3/4 medulloblastoma with known alterations in the oncogenes MYC, MYCN and PRDM6. We show that large-scale chromosomal aberrations are early tumour-initiating events, whereas the single-gene oncogenic events arise late and are typically subclonal, but MYC can become clonal upon disease progression to drive further tumour development and therapy resistance. Spatial transcriptomics shows that the subclones are mostly interspersed across tumour tissue, but clear segregation is also present. Using a population genetics model, we estimate medulloblastoma initiation in the cerebellar unipolar brush cell lineage starting from the first gestational trimester. Our findings demonstrate how single-cell technologies can be applied for early detection and diagnosis of this fatal disease.

Classification:

Note: DKFZ-ZMBH Alliance / #EA:B062#EA:B430#EA:B086#LA:B430#LA:B062# / 2025 Jun;642(8069):1062-1072

Contributing Institute(s):
  1. B062 Pädiatrische Neuroonkologie (B062)
  2. DKTK HD zentral (HD01)
  3. Entwicklungsbiolog. Ursprünge pädiatrischer Krebserkrankungen (B430)
  4. B086 Modellierung Biol. Systeme (B086)
  5. B066 Chromatin-Netzwerke (B066)
  6. Single-cell Open Lab (W192)
  7. Pädiatrische Gliomforschung (B360)
  8. KKE Neuropathologie (B300)
  9. KKE Pädiatrische Onkologie (B310)
  10. DKTK Koordinierungsstelle Frankfurt (FM01)
  11. B087 Neuroblastom Genomik (B087)
Research Program(s):
  1. 312 - Funktionelle und strukturelle Genomforschung (POF4-312) (POF4-312)

Appears in the scientific report 2025
Database coverage:
Medline ; BIOSIS Previews ; Biological Abstracts ; Chemical Reactions ; Clarivate Analytics Master Journal List ; Current Contents - Agriculture, Biology and Environmental Sciences ; Current Contents - Life Sciences ; Current Contents - Physical, Chemical and Earth Sciences ; DEAL Nature ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 60 ; Index Chemicus ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection ; Zoological Record
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database

 Record created 2025-05-08, last modified 2025-07-29



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)